This month the Galaxy Community announces the official launch of Galaxy India, and more! Galaxy...find out more
In an age of digital connectedness, open, highly accessible, globally shared data and analysis platforms have the potential to transform the way biomedical research is done, opening the way to ‘global research markets’, where competition arises from deriving understanding rather than access to samples and data. Other disciplines have embraced the benefits of global data generation and sharing, astronomy and high energy physics being two highly successful examples. We have the opportunity to mirror their successes in infrastructure funding by demonstrating that biological research can embrace the same global perspective on common infrastructure investment and data sharing.
Assoc Prof Andrew Lonie, Director, Australian BioCommons & Senior Advisor, Melbourne Bioinformatics